GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,000 | -63.3% | 425 | -50.0% | 0.00% | – |
| Q2 2021 | $30,000 | -11.8% | 850 | 0.0% | 0.00% | – |
| Q1 2021 | $34,000 | -83.2% | 850 | 0.0% | 0.00% | – |
| Q4 2020 | $202,000 | +339.1% | 850 | 0.0% | 0.00% | – |
| Q3 2020 | $46,000 | -14.8% | 850 | 0.0% | 0.00% | – |
| Q2 2020 | $54,000 | +145.5% | 850 | +100.0% | 0.00% | – |
| Q1 2020 | $22,000 | -35.3% | 425 | 0.0% | 0.00% | – |
| Q4 2019 | $34,000 | -15.0% | 425 | -48.8% | 0.00% | – |
| Q3 2019 | $40,000 | +81.8% | 830 | +95.3% | 0.00% | – |
| Q2 2019 | $22,000 | 0.0% | 425 | 0.0% | 0.00% | – |
| Q1 2019 | $22,000 | +29.4% | 425 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | +6.2% | 425 | 0.0% | 0.00% | – |
| Q3 2018 | $16,000 | -15.8% | 425 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | -9.5% | 425 | 0.0% | 0.00% | – |
| Q1 2018 | $21,000 | +23.5% | 425 | 0.0% | 0.00% | – |
| Q4 2017 | $17,000 | – | 425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |